Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network-Reference-Cited by-同舟云学术

Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network

Published:2012-11-21 Issue:4 Volume:54 Page:699-707
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Dreyling Martin,Kluin-Nelemans Hanneke C.,Beà Sílvia,Klapper Wolfram,Vogt Niclas,Delfau-Larue Marie-Helene,Hutter Grit,Cheah Chan,Chiappella Annalisa,Cortelazzo Sergio,Pott Christiane,Hess Georg,Visco Carlo,Vitolo Umberto,Klener Pavel,Aurer Igor,Unterhalt Michael,Ribrag Vincent,Hoster Eva,Hermine Olivier,

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.733882

Reference42 articles.

1. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

2. Specific Secondary Genetic Alterations in Mantle Cell Lymphoma Provide Prognostic Information Independent of the Gene Expression–Based Proliferation Signature

3. Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

4. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas

5. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP14 promotes the malignant progression and ibrutinib resistance of mantle cell lymphoma by stabilizing XPO1;International Journal of Medical Sciences;2023

2. Clinical and biological features of mantle cell lymphoma patients with co-expression of CD10 and BCL-6: a retrospective study;Translational Cancer Research;2021-11

3. B-cell lymphomas;Hematology and Coagulation;2020

4. TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant;Annals of Diagnostic Pathology;2019-08

5. Nomogram incorporating clinicopathological parameters to predict the survival of patients with mantle cell lymphoma;Journal of Investigative Medicine;2018-09-25